Cargando…

Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice

Lung metastasis is the major cause of death in patients with triple negative breast cancer (TNBC), an aggressive subtype of breast cancer with no effective therapy at present. It has been proposed that dual-targeted therapy, ie, targeting chemotherapeutic agents to both tumor vasculature and cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tian, Prasad, Preethy, Cai, Ping, He, Chunsheng, Shan, Dan, Rauth, Andrew Michael, Wu, Xiao Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520182/ https://www.ncbi.nlm.nih.gov/pubmed/28216624 http://dx.doi.org/10.1038/aps.2016.166

Ejemplares similares

Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer
por: Li, Xiang, et al.
Publicado: (2020)

Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
por: Solzak, Jeffrey P., et al.
Publicado: (2017)

Self-assembled albumin nanoparticles induce pyroptosis for photodynamic/photothermal/immuno synergistic therapies in triple-negative breast cancer
por: Yang, Jianquan, et al.
Publicado: (2023)

Nanomaterials with dual immunomodulatory functions for synergistic therapy of breast cancer brain metastases
por: Zhao, Zhenhao, et al.
Publicado: (2023)

A rare presentation of triple-negative apocrine breast carcinoma with metastases
por: Bedford, Tyler, et al.
Publicado: (2014)

Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells
por: Wu, Di, et al.
Publicado: (2019)

Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer
por: Rao, Shreyas S., et al.
Publicado: (2017)

A Dual-Mode Imaging Nanoparticle Probe Targeting PD-L1 for Triple-Negative Breast Cancer
por: Li, Xiajin, et al.
Publicado: (2022)

Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors
por: Qin, Ruoyan, et al.
Publicado: (2023)

Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases
por: Lee, Sang Min, et al.
Publicado: (2015)

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases
por: Anders, Carey, et al.
Publicado: (2014)

Layer-by-Layer Nanoparticles of Tamoxifen and Resveratrol for Dual Drug Delivery System and Potential Triple-Negative Breast Cancer Treatment
por: Al-jubori, Ali A., et al.
Publicado: (2021)

Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
por: Liu, Siyan, et al.
Publicado: (2022)

Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
por: Xiang, Jiajia, et al.
Publicado: (2023)

Peptide Nanoparticle-Mediated Combinatorial Delivery of Cancer-Related siRNAs for Synergistic Anti-Proliferative Activity in Triple Negative Breast Cancer Cells
por: Egorova, Anna, et al.
Publicado: (2021)

Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells
por: Bajor, Malgorzata, et al.
Publicado: (2020)

Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA
por: Zhou, Yang, et al.
Publicado: (2020)

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
por: Jin, Jia, et al.
Publicado: (2018)

THER-06. GENOMIC AND IMMUNE CHARACTERIZATION OF TRIPLE NEGATIVE BREAST CANCER BRAIN METASTASES
por: Vincent, Benjamin, et al.
Publicado: (2019)

Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer
por: Hamester, Fabienne, et al.
Publicado: (2022)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner, Jessica, et al.
Publicado: (2015)

Triple-Band Dual-Sense Circularly Polarized Hybrid Dielectric Resonator Antenna
por: Altaf, Amir, et al.
Publicado: (2018)

Pd Nanoparticles and MOFs Synergistically Hybridized Halloysite Nanotubes for Hydrogen Storage
por: Jin, Jiao, et al.
Publicado: (2017)

Significant response of low-dose apatinib monotherapy in brain metastases of triple-negative breast cancer: A case report
por: Li, Ting, et al.
Publicado: (2019)

Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer
por: Yellapu, Nanda Kumar, et al.
Publicado: (2022)

The synergistic effect of CDKN2B-AS1 and SPC25 on triple-negative breast cancer
por: Deng, Na, et al.
Publicado: (2022)

Synergistic effects of combined cisplatin and Clinacanthus nutans extract on triple negative breast cancer cells
por: Abu Bakar, Nur Fitriyani Afiqah Binti, et al.
Publicado: (2023)

Mesothelin Expression in Triple Negative Breast Carcinomas Correlates Significantly with Basal-Like Phenotype, Distant Metastases and Decreased Survival
por: Tozbikian, Gary, et al.
Publicado: (2014)

Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma
por: Yang, Ping, et al.
Publicado: (2020)

RNA nanoparticles for targeted therapies of triple-negative breast cancers
por: Danai, Leyla, et al.
Publicado: (2023)

Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma
por: Zhou, Yun, et al.
Publicado: (2021)

Role of palliative radiotherapy in the management of mural cardiac metastases: who, when and how to treat? A case series of 10 patients
por: Fotouhi Ghiam, Alireza, et al.
Publicado: (2016)

Hypoxia modulation by dual-drug nanoparticles for enhanced synergistic sonodynamic and starvation therapy
por: Wang, Jingxue, et al.
Publicado: (2021)

Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
por: Guo, Peng, et al.
Publicado: (2019)

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases
por: Laimito, Katerin Rojas, et al.
Publicado: (2016)

Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
por: Camorani, Simona, et al.
Publicado: (2018)

CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
por: Petruk, Nataliia, et al.
Publicado: (2021)

Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers
por: Bryan, Sarah, et al.
Publicado: (2021)

Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419
por: Routh, Eric D., et al.
Publicado: (2022)

A Comprehensive Evaluation of ZrC Nanoparticle in Combined Photothermal and Radiation Therapy for Treatment of Triple-Negative Breast Cancer
por: Jiang, Shan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k7dc4nd5kjpvhqv84p5p98i5gd